Aries Wealth Management Buys 175 Shares of Oracle Corporation $ORCL

Aries Wealth Management raised its stake in shares of Oracle Corporation (NYSE:ORCL) by 2.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,881 shares of the enterprise software provider’s stock after acquiring an additional 175 shares during the period. Aries Wealth Management’s holdings in Oracle were worth $1,504,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in ORCL. Nuveen LLC purchased a new stake in shares of Oracle during the 1st quarter valued at $732,692,000. Vanguard Group Inc. increased its position in shares of Oracle by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock valued at $22,498,982,000 after purchasing an additional 3,513,464 shares during the last quarter. Kingstone Capital Partners Texas LLC purchased a new stake in shares of Oracle during the 2nd quarter valued at $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Oracle by 79.2% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock valued at $648,572,000 after purchasing an additional 2,049,687 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its holdings in Oracle by 840.7% in the 2nd quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock worth $463,380,000 after acquiring an additional 1,894,157 shares during the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ORCL has been the subject of a number of research reports. Cowen reiterated a “buy” rating and set a $375.00 target price on shares of Oracle in a research report on Wednesday, September 10th. Robert W. Baird began coverage on shares of Oracle in a report on Wednesday, October 8th. They issued an “outperform” rating and a $365.00 price objective for the company. Guggenheim boosted their target price on shares of Oracle from $250.00 to $375.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Evercore ISI increased their target price on Oracle from $340.00 to $350.00 and gave the stock an “outperform” rating in a research report on Friday. Finally, Scotiabank reiterated an “outperform” rating on shares of Oracle in a research report on Wednesday, September 10th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $307.00.

Oracle Trading Down 2.8%

Shares of ORCL opened at $299.33 on Wednesday. The business’s 50-day moving average price is $268.67 and its 200-day moving average price is $212.52. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The stock has a market cap of $853.32 billion, a PE ratio of 69.29, a P/E/G ratio of 3.31 and a beta of 1.53. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCL) last announced its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same quarter in the prior year, the company earned $1.39 earnings per share. The company’s quarterly revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities analysts forecast that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle’s dividend payout ratio (DPR) is 46.30%.

Insider Activity

In other news, insider Clayton M. Magouyrk sold 21,241 shares of Oracle stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the completion of the sale, the insider owned 78,000 shares in the company, valued at approximately $23,174,580. This trade represents a 21.40% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William G. Parrett sold 11,500 shares of Oracle stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $306.00, for a total value of $3,519,000.00. Following the sale, the director owned 17,764 shares of the company’s stock, valued at approximately $5,435,784. This trade represents a 39.30% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 120,769 shares of company stock worth $36,428,967. Company insiders own 40.90% of the company’s stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.